Sandell Scott D
Director, 10% owner at NEUE; Director at NET; 10% owner at CBIO, and 32 more
- Sold, on record
- $1.1B
- Dollars the filings state
- Form 4 sales
- 93
- Latest Oct 2, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 35
- Filed as an executive or holder
Companies
- NEUENeueHealth, Inc.Director, 10% owner
- NETCloudflare, Inc.Director
- CBIOGLYCOMIMETICS INC10% owner
- ACLXArcellx, Inc.10% owner
- GENOCEA BIOSCIENCES, INC.10% owner
- HOODRobinhood Markets, Inc.Director
- ELVNEnliven Therapeutics, Inc.10% owner
- Metacrine, Inc.10% owner
- ARDXARDELYX, INC.10% owner
- SPTSprout Social, Inc.10% owner
- SENSSenseonics Holdings, Inc.10% owner
- Mersana Therapeutics, Inc.10% owner
- TRVITrevi Therapeutics, Inc.10% owner
- KINETA, INC./DE10% owner
- ORKAOruka Therapeutics, Inc.10% owner
- APPNAPPIAN CORP10% owner
- Ra Pharmaceuticals, Inc.10% owner
- Zosano Pharma Corp10% owner
- SUPNSUPERNUS PHARMACEUTICALS, INC.10% owner
- TESARO, Inc.10% owner
- Tableau Software IncDirector
- VIRXViracta Therapeutics, Inc.10% owner
- CVENT INC10% owner
- Epizyme, Inc.10% owner
- HYPERION THERAPEUTICS INC10% owner
- WDAYWorkday, Inc.Director
- BOINGO WIRELESS INC10% owner
- GYREGYRE THERAPEUTICS, INC.10% owner
- AUDIENCE INC10% owner
- GRPNGroupon, Inc.10% owner
- Omthera Pharmaceuticals, Inc.10% owner
- FUSION-IO, INC.Director
- Millennial Media Inc.10% owner
- INNERWORKINGS INC10% owner
- Data Domain, Inc.Director, 10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Tableau Software Inc10.4M shares
- GENOCEA BIOSCIENCES, INC.10.4M shares
- CBIO4.1M shares
- SPT3.4M shares
- APPN3.4M shares
- ARDX3M shares
- NET2.9M shares
- Millennial Media Inc.1.6M shares
- ORKA1.5M shares
- FUSION-IO, INC.1.4M shares
- CVENT INC1.3M shares
- KINETA, INC./DE1.3M shares
- INNERWORKINGS INC1.1M shares
- Data Domain, Inc.1.1M shares
- VIRX977,240 shares
- SENS546,962 shares
- Metacrine, Inc.497,270 shares
- SUPN232,034 shares
- ELVN116,476 shares
- GRPN35,287 shares
- Mersana Therapeutics, Inc.24,323 shares
- WDAY20,250 shares
- HOOD12,826 shares
- Zosano Pharma Corp7,471 shares
- TESARO, Inc.7,045 shares
- AUDIENCE INC6,386 shares
- GYRE6,333 shares
- NEUE4,195 shares
- BOINGO WIRELESS INC4,189 shares
- Epizyme, Inc.3,411 shares
- HYPERION THERAPEUTICS INC1,430 shares
- ACLX569 shares
- TRVI564 shares
- Ra Pharmaceuticals, Inc.435 shares
- Omthera Pharmaceuticals, Inc.196 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ACLXUnusualDec 21 2022
Sold 179 shares at $30.74 ($6k)
Sandell Scott D, 10% owner
Sold 100% of holdings ($6k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale ACLXUnusualDec 23 +2 days
Sold 390 shares at $31.67 ($12k)
Sandell Scott D, 10% owner
Sold 100% of holdings ($12k position)0 shares leftFiling
- 3 Form 4 sale CBIOPlan not statedJan 4 +12 days
Sold 398,133 shares at $2.98 ($1.2M)
Sandell Scott D, 10% owner
Sold 9.2% of holdings ($12.8M position)3.9M shares leftFirst sale on recordFiling
- 4 Form 4 sale CBIOPlan not statedJan 5 +1 day
Sold 71,362 shares at $2.76 ($197k)
Sandell Scott D, 10% owner
Sold 1.8% of holdings ($10.9M position)3.9M shares leftFiling
- 5 Form 4 sale CBIOUnusualJan 26 +21 days
Sold 3.7M shares at $3.14 ($11.5M)
Sandell Scott D, 10% owner
Sold 62% of holdings ($18.5M position)2.2M shares leftFiling
- 6 Form 4 sale NETUnusualAug 8 +194 days
Sold 20,307 shares at $65.26 ($1.3M)
Sandell Scott D, Director
No 10b5-1 planSold 100% of holdings ($1.3M position)0 shares leftFiling
- 7 Form 4 sale NETUnusualNov 20 +104 days
Sold 211,534 shares at $73.17 ($15.5M)
Sandell Scott D, Director
10b5-1 planSold 100% of holdings ($15.5M position)0 shares left31.9x usual sizeFiling
- 8 Form 4 sale NEUENo planOct 2 +682 days
Sold 4,195 shares at $6.75 ($28k)
Sandell Scott D, Director, 10% owner
No 10b5-1 planSold 0.2% of holdings ($15.3M position)2.3M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (93)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | NEUE | Director, 10% owner | Form 4 sale | 4,195 | $28k | 0.2% | No plan | SEC |
| Nov 20, 2023 | NET | Director | Form 4 sale | 211,534 | $15.5M | 100.0% | Unusual | SEC |
| Aug 8, 2023 | NET | Director | Form 4 sale | 20,307 | $1.3M | 100.0% | Unusual | SEC |
| Jan 26, 2023 | CBIO | 10% owner | Form 4 sale | 3.7M | $11.5M | 62.0% | Unusual | SEC |
| Jan 5, 2023 | CBIO | 10% owner | Form 4 sale | 71,362 | $197k | 1.8% | Plan not stated | SEC |
| Jan 4, 2023 | CBIO | 10% owner | Form 4 sale | 398,133 | $1.2M | 9.2% | Plan not stated | SEC |
| Dec 23, 2022 | ACLX | 10% owner | Form 4 sale | 390 | $12k | 100.0% | Unusual | SEC |
| Dec 21, 2022 | ACLX | 10% owner | Form 4 sale | 179 | $6k | 100.0% | Unusual | SEC |
| Jun 14, 2022 | NET | Director | Form 4 sale | 2,441 | $100k | 41.4% | Unusual | SEC |
| May 25, 2022 | GENOCEA BIOSCIENCES, INC. | 10% owner | Form 4 sale | 10.4M | $771k | 100.0% | Unusual | SEC |
| May 12, 2022 | HOOD | Director | Form 4 sale | 8,792 | $74k | 100.0% | Unusual | SEC |
| May 3, 2022 | HOOD | Director | Form 4 sale | 1,952 | $20k | 100.0% | Unusual | SEC |
| Feb 14, 2022 | NET | Director | Form 4 sale | 6,622 | $701k | 73.1% | Unusual | SEC |
| Jan 31, 2022 | HOOD | Director | Form 4 sale | 2,082 | $30k | 100.0% | Unusual | SEC |
| Jan 3, 2022 | ELVN | 10% owner | Form 4 sale | 116,476 | $267k | 3.2% | Plan not stated | SEC |
| Dec 22, 2021 | Metacrine, Inc. | 10% owner | Form 4 sale | 497,270 | $494k | 16.2% | Plan not stated | SEC |
| Dec 15, 2021 | ARDX | 10% owner | Form 4 sale | 2.9M | $3.6M | 56.1% | Unusual | SEC |
| Nov 20, 2020 | NET | Director | Form 4 sale | 337,404 | $22.3M | 100.0% | Unusual | SEC |
| Nov 18, 2020 | NET | Director | Form 4 sale | 450,579 | $29.4M | 57.2% | Unusual | SEC |
| Nov 13, 2020 | NET | Director, 10% owner | Form 4 sale | 85,680 | $5.5M | 9.8% | Plan not stated | SEC |
| Aug 20, 2020 | NET | Director, 10% owner | Form 4 sale | 439,300 | $17.6M | 100.0% | Unusual | SEC |
| Aug 18, 2020 | NET | Director, 10% owner | Form 4 sale | 250,700 | $9.9M | 36.3% | Unusual | SEC |
| Aug 17, 2020 | SPT | 10% owner | Form 4 sale | 3.4M | $94.7M | 38.1% | Unusual | SEC |
| Aug 13, 2020 | NET | Director, 10% owner | Form 4 sale | 615,846 | $23.6M | 47.2% | Unusual | SEC |
| Aug 10, 2020 | NET | Director, 10% owner | Form 4 sale | 92,163 | $3.4M | 6.6% | Plan not stated | SEC |
| Jun 15, 2020 | ARDX | 10% owner | Form 4 sale | 43 | $274 | 100.0% | Unusual | SEC |
| Jun 12, 2020 | ARDX | 10% owner | Form 4 sale | 89,983 | $573k | 100.0% | Unusual | SEC |
| May 21, 2020 | NET | Director, 10% owner | Form 4 sale | 349,554 | $9.6M | 100.0% | Unusual | SEC |
| Apr 22, 2020 | SENS | 10% owner | Form 4 sale | 165,061 | $105k | 0.8% | Plan not stated | SEC |
| Apr 20, 2020 | SENS | 10% owner | Form 4 sale | 203,584 | $139k | 1.0% | Plan not stated | SEC |
| Apr 15, 2020 | SENS | 10% owner | Form 4 sale | 178,317 | $120k | 0.9% | Plan not stated | SEC |
| Apr 14, 2020 | Mersana Therapeutics, Inc. | 10% owner | Form 4 sale | 2,198 | $20k | 100.0% | Unusual | SEC |
| Apr 13, 2020 | Mersana Therapeutics, Inc. | 10% owner | Form 4 sale | 20,914 | $178k | 100.0% | Unusual | SEC |
| Apr 3, 2020 | TRVI | 10% owner | Form 4 sale | 564 | $2k | 0.0% | Plan not stated | SEC |
| Nov 27, 2019 | KINETA, INC./DE | 10% owner | Form 4 sale | 1.3M | $3.2M | 23.1% | Plan not stated | SEC |
| Aug 28, 2019 | Mersana Therapeutics, Inc. | 10% owner | Form 4 sale | 1,211 | $4k | 0.0% | Plan not stated | SEC |
| Nov 12, 2018 | ARDX | 10% owner | Form 4 sale | 592 | $2k | 100.0% | Unusual | SEC |
| May 10, 2018 | CBIO | 10% owner | Form 4 sale | 9,539 | $170k | 0.2% | Plan not stated | SEC |
| Feb 26, 2018 | ORKA | 10% owner | Form 4 sale | 1.5M | $730k | 100.0% | Unusual | SEC |
| Nov 27, 2017 | APPN | 10% owner | Form 4 sale | 569,620 | $11.1M | 100.0% | Unusual | SEC |
| Nov 20, 2017 | APPN | 10% owner | Form 4 sale | 2.8M | $55M | 100.0% | Unusual | SEC |
| Oct 31, 2016 | Ra Pharmaceuticals, Inc. | 10% owner | Form 4 sale | 435 | $6k | 0.5% | Plan not stated | SEC |
| Sep 16, 2016 | Zosano Pharma Corp | 10% owner | Form 4 sale | 7,471 | $6k | 0.4% | Plan not stated | SEC |
| Nov 16, 2015 | CBIO | 10% owner | Form 4 sale | 452 | $3k | 0.0% | Plan not stated | SEC |
| Jun 17, 2015 | SUPN | 10% owner | Form 4 sale | 136,597 | $2.3M | 100.0% | Unusual | SEC |
| Jun 16, 2015 | SUPN | 10% owner | Form 4 sale | 95,437 | $1.6M | 46.0% | Unusual | SEC |
| Jun 2, 2015 | TESARO, Inc. | 10% owner | Form 4 sale | 2,633 | $153k | 100.0% | Unusual | SEC |
| Dec 26, 2014 | ARDX | 10% owner | Form 4 sale | 1,972 | $42k | 100.0% | Unusual | SEC |
| Dec 5, 2014 | Tableau Software Inc | Director | Form 4 sale | 17,123 | $1.4M | 100.0% | Unusual | SEC |
| Dec 4, 2014 | Tableau Software Inc | Director, 10% owner | Form 4 sale | 52,449 | $4.3M | 75.4% | Unusual | SEC |
| Aug 29, 2014 | VIRX | 10% owner | Form 4 sale | 266,700 | $2.1M | 5.4% | Plan not stated | SEC |
| Aug 25, 2014 | Tableau Software Inc | Director, 10% owner | Form 4 sale | 7,099 | $429k | 100.0% | Unusual | SEC |
| Aug 22, 2014 | Tableau Software Inc | Director, 10% owner | Form 4 sale | 52,312 | $3.2M | 88.1% | Unusual | SEC |
| Aug 21, 2014 | Tableau Software Inc | Director, 10% owner | Form 4 sale | 30,000 | $1.8M | 33.6% | Unusual | SEC |
| Aug 15, 2014 | CVENT INC | 10% owner | Form 4 sale | 2,641 | $69k | 100.0% | Unusual | SEC |
| Aug 15, 2014 | Epizyme, Inc. | 10% owner | Form 4 sale | 3,411 | $125k | 100.0% | Unusual | SEC |
| Aug 12, 2014 | VIRX | 10% owner | Form 4 sale | 710,540 | $4.7M | 12.6% | Plan not stated | SEC |
| Jun 6, 2014 | HYPERION THERAPEUTICS INC | 10% owner | Form 4 sale | 1,430 | $8k | 100.0% | Unusual | SEC |
| Mar 7, 2014 | Tableau Software Inc | Director, 10% owner | Form 4 sale | 23,624 | $2.1M | 40.3% | Unusual | SEC |
| Mar 6, 2014 | Tableau Software Inc | Director, 10% owner | Form 4 sale | 84,849 | $8.1M | 59.1% | Unusual | SEC |
| Mar 5, 2014 | Tableau Software Inc | Director, 10% owner | Form 4 sale | 35,000 | $3.3M | 100.0% | Unusual | SEC |
| Mar 4, 2014 | Tableau Software Inc | Director, 10% owner | Form 4 sale | 40,804 | $3.9M | 68.0% | Unusual | SEC |
| Feb 28, 2014 | WDAY | Director | Form 4 sale | 4,930 | $535k | 100.0% | Unusual | SEC |
| Feb 27, 2014 | Tableau Software Inc | Director, 10% owner | Form 4 sale | 188,452 | $18M | 75.9% | Unusual | SEC |
| Jan 21, 2014 | CVENT INC | 10% owner | Form 4 sale | 169,887 | $6M | 2.8% | Plan not stated | SEC |
| Jan 16, 2014 | CVENT INC | 10% owner | Form 4 sale | 1.1M | $40.2M | 15.5% | Plan not stated | SEC |
| Dec 11, 2013 | BOINGO WIRELESS INC | 10% owner | Form 4 sale | 2,775 | $17k | 100.0% | Unusual | SEC |
| Dec 9, 2013 | WDAY | Director | Form 4 sale | 4,924 | $392k | 50.0% | Unusual | SEC |
| Dec 5, 2013 | GYRE | 10% owner | Form 4 sale | 1,000 | $5k | 100.0% | Unusual | SEC |
| Nov 21, 2013 | GYRE | 10% owner | Form 4 sale | 5,333 | $28k | 84.2% | Unusual | SEC |
| Nov 20, 2013 | Tableau Software Inc | Director, 10% owner | Form 4 sale | 1.2M | $72.3M | 100.0% | Unusual | SEC |
| Nov 13, 2013 | Tableau Software Inc | Director, 10% owner | Form 4 sale | 6.8M | $424M | 100.0% | Unusual | SEC |
| Nov 5, 2013 | AUDIENCE INC | 10% owner | Form 4 sale | 2,573 | $25k | 100.0% | Unusual | SEC |
| Aug 22, 2013 | BOINGO WIRELESS INC | 10% owner | Form 4 sale | 1,414 | $10k | 100.0% | Unusual | SEC |
| Aug 15, 2013 | GRPN | 10% owner | Form 4 sale | 35,287 | $345k | 100.0% | Unusual | SEC |
| Jun 5, 2013 | TESARO, Inc. | 10% owner | Form 4 sale | 4,412 | $173k | 100.0% | Unusual | SEC |
| May 22, 2013 | Tableau Software Inc | Director, 10% owner | Form 4 sale | 2M | $57.7M | 100.0% | Unusual | SEC |
| Apr 16, 2013 | Omthera Pharmaceuticals, Inc. | 10% owner | Form 4 sale | 196 | $2k | 0.1% | Plan not stated | SEC |
| Apr 10, 2013 | WDAY | Director, 10% owner | Form 4 sale | 10,396 | $606k | 100.0% | Unusual | SEC |
| Mar 7, 2013 | AUDIENCE INC | 10% owner | Form 4 sale | 3,813 | $50k | 100.0% | Unusual | SEC |
| Dec 6, 2012 | FUSION-IO, INC. | Director | Form 4 sale | 4,603 | $104k | 100.0% | Unusual | SEC |
| Oct 29, 2012 | Millennial Media Inc. | 10% owner | Form 4 sale | 1.6M | $21.5M | 16.3% | Plan not stated | SEC |
| Sep 5, 2012 | FUSION-IO, INC. | Director, 10% owner | Form 4 sale | 80,057 | $2.2M | 100.0% | Unusual | SEC |
| Apr 30, 2012 | FUSION-IO, INC. | Director, 10% owner | Form 4 sale | 20,249 | $536k | 100.0% | Unusual | SEC |
| Feb 29, 2012 | INNERWORKINGS INC | 10% owner | Form 4 sale | 455,360 | $5.2M | 7.0% | Plan not stated | SEC |
| Feb 24, 2012 | INNERWORKINGS INC | 10% owner | Form 4 sale | 334,457 | $3.8M | 4.9% | Plan not stated | SEC |
| Feb 23, 2012 | INNERWORKINGS INC | 10% owner | Form 4 sale | 310,273 | $3.6M | 4.4% | Plan not stated | SEC |
| Feb 14, 2012 | FUSION-IO, INC. | Director, 10% owner | Form 4 sale | 4,462 | $102k | 100.0% | Unusual | SEC |
| Feb 6, 2012 | FUSION-IO, INC. | Director, 10% owner | Form 4 sale | 27,437 | $631k | 29.8% | Unusual | SEC |
| Nov 28, 2011 | FUSION-IO, INC. | Director, 10% owner | Form 4 sale | 1.3M | $41.1M | 93.7% | Unusual | SEC |
| Dec 3, 2007 | Data Domain, Inc. | Director, 10% owner | Form 4 sale | 90,575 | $2.3M | 0.8% | Plan not stated | SEC |
| Nov 21, 2007 | Data Domain, Inc. | Director, 10% owner | Form 4 sale | 965,385 | $25M | 7.5% | Plan not stated | SEC |
| Nov 12, 2007 | INNERWORKINGS INC | 10% owner | Form 4 sale | 729 | $10k | 100.0% | Unusual | SEC |